Filing Details

Accession Number:
0001209191-20-029246
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-14 17:29:22
Reporting Period:
2020-05-14
Accepted Time:
2020-05-14 17:29:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382101 Sutro Biopharma Inc. STRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1309660 J William Newell C/O Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco CA 94080
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-14 64,516 $7.75 166,627 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,577 Indirect Newell Family Revocable Trust DTD 08/14/1998
Common Stock 26,091 Indirect Taluswood Partners, L.P.
Footnotes
  1. These securities are held of record by the reporting person as trustee of the Newell Family Revocable Trust DTD 08/14/2008.
  2. The reporting person is the general partner of Taluswood Partners, L.P. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.